FLT3 and acute myeloid leukemia: Lyn is over-expressed and active in most clinical AML isolates and has been linked to the activation of Stat5 by Flt3-ITD (Robinson et al., 2005; Okamoto et al., 2007; Dos Santos et al., 2008).